Bitler, B. G., Aird, K. M., & Zhang, R. (2016). Epigenetic synthetic lethality in ovarian clear cell carcinoma: EZH2 and ARID1A mutations. Molecular & Cellular Oncology, 3(1), 1. https://doi.org/10.1080/23723556.2015.1032476
Chicago Style (17th ed.) CitationBitler, Benjamin G., Katherine M. Aird, and Rugang Zhang. "Epigenetic Synthetic Lethality in Ovarian Clear Cell Carcinoma: EZH2 and ARID1A Mutations." Molecular & Cellular Oncology 3, no. 1 (2016): 1. https://doi.org/10.1080/23723556.2015.1032476.
MLA (9th ed.) CitationBitler, Benjamin G., et al. "Epigenetic Synthetic Lethality in Ovarian Clear Cell Carcinoma: EZH2 and ARID1A Mutations." Molecular & Cellular Oncology, vol. 3, no. 1, 2016, p. 1, https://doi.org/10.1080/23723556.2015.1032476.